NHC
GILD icon

Nicholas Hoffman & Company’s Gilead Sciences GILD Stock Holding History

Nicholas Hoffman & Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232K Buy
1,833
+14
+0.8% +$1.84K ﹤0.01% 324
2026
Q1 		$254K Hold
1,819
– – 0.01% 297
2025
Q4 		$223K Buy
+1,819
New +$221K 0.01% 303
2024
Q3 		– Sell
-4,387
Closed -$301K – 296
2024
Q2 		$301K Buy
+4,387
New +$293K 0.01% 241

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Nicholas Hoffman & Company's GILD Position: Q2 2026 in Review

Nicholas Hoffman & Company increased its Gilead Sciences (GILD) stake by 0.77% in Q2 2026, buying an estimated $1.84K and bringing the position to 1,833 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #324.

Nicholas Hoffman & Company first reported a position in GILD in Q2 2024 and has held it in 4 quarters since. The position peaked at $301K in Q2 2024. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Nicholas Hoffman & Company held 1,833 shares of Gilead Sciences worth $232K as of Q2 2026.
  • Nicholas Hoffman & Company bought 14 Gilead Sciences shares in Q2 2026, an estimated $1.84K.
  • Gilead Sciences made up ﹤0.01% of Nicholas Hoffman & Company's portfolio in Q2 2026, its #324 holding.
  • Nicholas Hoffman & Company first reported a position in Gilead Sciences in Q2 2024 and has held it in 4 quarters since.
  • Nicholas Hoffman & Company's Gilead Sciences position peaked at $301K in Q2 2024.
  • 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Nicholas Hoffman & Company's 13F filing for Q2 2026, filed 4 Aug 2026.